Monaco's chief executive Thiago Scuro has publicly blamed Everton for the collapse of Folarin Balogun's £40m transfer, alleging the Merseyside club mishandled the striker's medical assessment. The 25‑year‑old US international had submitted a deal sheet just before the deadline, only to reverse his decision hours later.
Medical dispute triggers last‑minute reversal
Everton's medical team reportedly raised concerns after the initial scan, prompting the club to renegotiate the fee structure with Monaco. Scuro says the club's approach to the medical was "unprofessional" and that the ensuing uncertainty made Balogun uncomfortable with the move.
Everton's frantic deadline‑day maneuvers
Facing a dwindling window, Everton also attempted to secure loan deals for Joshua Zirkzee and Tammy Abraham, but those options fell through. The club then turned its attention to Balogun, believing the young striker could bolster a faltering attack. When the medical issue emerged, Everton altered the payment schedule, a decision Scuro claims was a reaction to the discovered problem rather than a strategic adjustment.
Monaco defends its stance on Lamine Camara
In the same statement, Scuro also addressed rumors surrounding Lamine Camara, a promising talent linked with Chelsea. The club confirmed that it had not entered any agreement with the Blues, emphasizing that Camara remains a Monaco asset and that any speculation was premature.
What the fallout means for both clubs
Everton now face a midfield void as they head into the new season without the anticipated strike‑partner for their forwards. The aborted deal also highlights the club's precarious transfer strategy, having failed to secure alternative options before the deadline. For Monaco, retaining Balogun preserves a valuable asset and signals that the club will not be pressured into a sale under questionable circumstances.
Balogun's future prospects
At 25, Balogun has already earned caps for the United States and shown a keen eye for goal in Ligue 1. His market value remains high, and the episode may deter clubs from pushing medical negotiations too aggressively. The striker is expected to resume pre‑season preparations with Monaco, where he will continue to be a key figure in the club's attacking plans.
Overall, the incident underscores how delicate transfer negotiations can become when medicals, fee structures, and deadline pressure intersect. Both parties will likely review their processes to avoid similar breakdowns in future windows.
Everton's handling of the medical was a clear misstep that cost them a marquee signing, while Monaco showed resolve by protecting Balogun's interests. The club's decision to walk away was the right one for the player.
Everton must now look elsewhere to reinforce their attack, potentially turning to the summer market with less bargaining power. Monaco retains a proven striker, keeping their offensive options intact and preserving a valuable resale asset.
Preguntas Frecuentes
Monaco says Everton's handling of his medical assessment was unprofessional, leading the striker to withdraw his agreement.
The deal was reported to be worth £40 million.
Yes, Monaco confirmed that Camara remains at the club and no deal with Chelsea was reached.